棕化调节北上腺素载体的吸收,表面局部化和总表达,在姿势正静性高心率综合征中具有病原性影响
Christopher R Brown1, Madhur Shetty1, James D Foster1
1Department of Biomedical Sciences, University of North Dakota School of Medicine and Health Sciences, Grand Forks, North Dakota, USA.
Journal of neurochemistry
|October 12, 2024
概括
上腺素载体 (NET) 棕化是上腺素恒温的关键调节机制. 这项研究表明,抑制细胞中的NET棕化会降低NET的表达和功能,可能导致POTS等疾病.
科学领域:
- 生物化学 生物化学
- 细胞生物学 细胞生物学
- 神经科学是一个神经科学.
背景情况:
- 姿势静止性心力衰竭综合征 (POTS) 与上腺体信号功能障碍有关.
- 上腺素运输体 (NET) 调节了类甲醇胺水平,对上腺素平衡至关重要.
- NET在神经和上腺功能障碍中的作用正在调查中.
研究的目的:
- 调查S-palmitoylation在调节北上腺素运输体 (NET) 表达和功能的作用.
- 为了确定NET棕化是否在POTS等条件下失调.
主要方法:
- 利用雄性Sprague-Dawley大鼠和LCL-PK1细胞来研究NET棕化.
- 采用了DHHC抑制剂2-bromopalmitate (2BP) 来评估对NET的影响.
- 研究了与DHHC酶共同表达NET的效果,包括DHHC1.
- 分析了一种与POTS相关的NET突变 (A457P) 和一种具有修饰N端半氨酸的变体.
主要成果:
- 在LLC-PK1细胞中,NET经历动态S-棕化.
- 用2BP抑制棕化减少了NET表面和总表达,以及运输能力.
- DHHC1联合表达增强了野生类型的NET棕化和蛋白质水平.
- 与POTS相关的NET突变 (A457P) 显示功能和表面表达受损,DHHC1联合表达无法挽救.
结论:
- 棕化是一种新的调节NET的机制.
- NET棕化失调可能会导致上腺功能障碍的发病,包括POTS.
- 需要进一步的研究,以充分阐明NET棕化在POTS和相关疾病中的作用.
相关概念视频
Drugs Affecting Neurotransmitter Release or Uptake
970
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
970
Transducer Mechanism: Enzyme-Linked Receptors
2.4K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.4K
Adrenergic Neurons: Neurotransmission
3.4K
Postganglionic sympathetic fibers (except those supplying the sweat glands) releasing noradrenaline or norepinephrine are called noradrenergic or adrenergic neurons. Noradrenaline, dopamine, adrenaline, or epinephrine are collectively called "catecholamines" as they contain a catechol moiety and an amine side chain. The five stages of neurotransmitter release involve their synthesis, storage, release, reuptake and metabolism.
Synthesis: Catecholamine synthesis requires tyrosine, which...
Synthesis: Catecholamine synthesis requires tyrosine, which...
3.4K
Neurochemical Transmission: Sites of Drug Action
2.1K
Neurochemical transmission, the conduction of electrical impulses between neurons mediated by neurotransmitters, plays a vital role in various physiological processes. Autonomic drugs exert their effects by modulating neurotransmission within the autonomic nervous system. For instance, drugs such as hemicholinium block the precursor uptake necessary for synthesizing acetylcholine, an essential autonomic neurotransmitter. Following synthesis, neurotransmitters are stored in vesicles. Metyrosine...
2.1K
Drugs Affecting Neurotransmitter Synthesis
1.3K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.3K
Regulation of Nuclear Protein Sorting
2.4K
Nuclear protein sorting regulates nucleus composition and gene expression, crucial for determining the fate of a eukaryotic cell. Hence, the entry and exit of molecules across the nuclear envelope is a tightly controlled process. Nuclear protein sorting can be inhibited by one of the following ways: 1) masking cargo signal sequences, 2) modifying the nuclear receptor's affinity for cargo, 3) controlling the nuclear pore size, 4) retaining the cargo during its transit to the cytosol or the...
2.4K


